Global Pelvic Organ Prolapse Devices Market: Introduction
A pelvic organ prolapse is a medical condition where one of the pelvic organs descends lower than its normal anatomical position in the pelvic region. In a pelvic organ prolapse, pelvic organs, such as small intestine, bladder, uterus, bowel, or part of the vagina, which are usually supported by the pelvic floor, protrude or herniate into or at times even beyond the vaginal opening owing to weakened supporting structure of the pelvic floor. There are various types of pelvic prolapses depending on which organ has prolapsed. The prolapse of the bladder is known as cystocele. The prolapse of the small bowel is known as enterocele. When there is a prolapse of the rectum, it is called rectocele. Uterine prolapse is when the uterus descends down from its original position. The uterus, which aids in supporting the top of the vagina, when removed, at times causes the drop of the upper portion of the vagina, which is known as a vaginal vault prolapse. The devices used to restore the pelvic organs to their original position or that offer support to keep the pelvic organs in their natural position are called pelvic organ prolapse devices.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=Brep_id=46365
Key Drivers of Global Pelvic Organ Prolapse Devices Market
Increase in Geriatric Population
According to the WHO, the global population is increasing at the annual rate of 1.7%, while the population of those over 65 years is increasing at a rate of 2.5%. The fastest growing population segment in most countries is adults older than 80 years, which, according to the United Nations estimates, is likely to account for nearly 20% of the world’s population. Nutritional risk factors in the geriatric population and careful screening can intervene in the early stages, which can be termed valuable and effective. According to the World Population Ageing (2017), the global population aged 60 years or over stood at 962 million in 2017, more than twice as large as in 1980 when there were 382 million geriatric people. The geriatric population is expected to double by 2050 and projected to reach nearly 2.1 billion. In 2050, elderly persons are expected to account for 35% of the population of Europe, 28% of North America, 25% of Latin America the Caribbean, 24% of Asia, 23% of Oceania, and 9% of Africa. The geriatric population in developing regions is increasing at a more rapid pace compared to the developed regions.
Request for Analysis of COVID19 Impact on Pelvic Organ Prolapse Devices Market –
Rise in Prevalence of Pelvic Organ Prolapse
Pelvic organ prolapse when defined by symptoms has a prevalence of 3% to 6% and up to 50% when based upon vaginal examination. Surgery for prolapse is performed twice as commonly as continence surgery and prevalence varies from 6% to 18%. The incidence of pelvic organ prolapse ranges from 1.5 to 1.8 per 1,000 women and peaks in women aged 60 to 69. According to BioMed Central Ltd., the prevalence of pelvic organ prolapse based on clinical examination of symptomatic women was found to be 10.3% (95% CI 9–11%) among women aged 15 years or older.
Pre book Market Report -
North America to Account for Major Share of Global Pelvic Organ Prolapse Devices Market
North America is projected to account for major share of the global pelvic organ prolapse devices market during the forecast period. This is attributed to 200,000 prolapse surgeries performed in the U.S each year, and nearly 24% of women in the U.S. are affected with one or more pelvic floor disorders in their lifetime. The market in the region is anticipated to expand at a rapid pace in the next few years due to increase in research development and technologically advanced products introduced in the market. Europe is expected to be the second largest market during the forecast period owing to advanced facilities provided by the hospital infrastructure.
Read More Information:
Key Players Operating in Global Pelvic Organ Prolapse Devices Market
The global pelvic organ prolapse devices market is highly consolidated owing to the presence of small number of key players. Leading players operating in the global pelvic organ prolapse devices market are:
- Ethicon US, LLC
- Boston Scientific Corporation
- Coloplast Ltd.
- CooperSurgical, Inc.
- MedGyn Products, Inc.
- Personal Medical Corp.
- Dr. Arabin GmbH Co. KG
- Integra LifeSciences Corporation
- Panpac Medical Corporation
- medesign I.C. GmbH
Browse More Trending Reports by Transparency Market Research:
Medical Sensors Market:
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453